Understanding Allergies and Sensitizations in Healthy and Allergic Individuals
Launched by STANFORD UNIVERSITY · Mar 30, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Understanding Allergies and Sensitizations in Healthy and Allergic Individuals," aims to improve how we diagnose allergies and understand the changes in the body that happen with allergic diseases. Researchers want to learn more about the different factors that contribute to allergies, including genetic and physical changes.
The study is currently looking for participants of all ages, from 7 years old and up, who may have allergies. However, individuals who have special risks related to blood draws will not be able to participate. If you join the study, you can expect to undergo some tests and assessments that will help researchers gather important information about allergies. Your involvement could help improve allergy diagnosis and treatment in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Any individual with possible allergy
- Exclusion Criteria:
- • Patients with special risks attendant to venipuncture will be excluded
About Stanford University
Stanford University is a prestigious academic institution renowned for its cutting-edge research and innovation in healthcare and medicine. As a clinical trial sponsor, Stanford leverages its extensive resources, including a collaborative network of world-class researchers and state-of-the-art facilities, to advance medical knowledge and improve patient care. The university is committed to conducting rigorous, ethical research that adheres to the highest standards of scientific integrity, fostering an environment where groundbreaking discoveries can translate into effective clinical applications. Through its clinical trials, Stanford aims to address critical health challenges and contribute to the development of novel therapies and treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mountain View, California, United States
Palo Alto, California, United States
Patients applied
Trial Officials
R. Sharon Chinthrajah, MD
Principal Investigator
Stanford University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials